Seeking Alpha

Needham starts TetraLogic Pharma at Buy

  • Recently public TetraLogic Pharmaceuticals (TLOG +4%) trades higher in early action.
  • Helping the cause is Needham's Chad Messer, who has initiated the shares at Buy with a $16 price target.
  • TLOG "is now developing birinapant as a best-in-class IAP inhibitor with a well established safety profile in multiple indications for cancer and infectious disease," Messer notes.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: